Prognostic Utility of a Multi-Gene Signature After Radical Nephrectomy Feldman, Adam S.; Morgan, Todd Feldman, Adam S.; Morgan, Todd Less Oncology Times. 38(16):6-7, August 25, 2016. Favorite PDF Permissions Free
Gene Expression Profile May ID Patients Unlikely to Benefit From Nivolumab Less Oncology Times. 38(16):8, August 25, 2016. Favorite PDF Permissions Free
Time to Get Moving? The Potential for Exercise in Management of RCC Harrison, Michael R. Harrison, Michael R. Less Oncology Times. 38(16):9-10, August 25, 2016. Favorite PDF Permissions Free
Treatment Beyond Progression: Practicing Patience Hocevar, Robin Hocevar, Robin Less Oncology Times. 38(16):11-12, August 25, 2016. Favorite PDF Permissions Free
Findings of Long-Term Overall Survival With Nivolumab Hocevar, Robin Hocevar, Robin Less Oncology Times. 38(16):13-14, August 25, 2016. Favorite PDF Permissions Free
Various miRNAs Predict Effect of Anti-Angiogenic Agents on Renal Cancer Less Oncology Times. 38(16):15, August 25, 2016. Favorite PDF Permissions Free
3 Questions on...The Role of Cytoreductive Nephrectomy in Treating Metastatic RCC: With Toni K. Choueiri, MD, of Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 38(16):16, August 25, 2016. Favorite PDF Permissions Free
